ORIGINAL RESEARCH
Additional education in the field of biomedicine (Cellular and genetic therapy)
About authors
1 Federal State Autonomous Educational Institution of Higher Education «Russian National Research Medical University named after N.I. Pirogov» Ministry of Health of the Russian Federation
2 Federal State Budgetary Institution of Science “Institute of Developmental Biology named after N.K. Koltsov RAS”
3 Company «AkRusBiomed»
About paper
The work was financially supported by the Ministry of Science and Higher Education of the Russian Federation under Agreement No. 075-15-2021-1075 dated September 28, 2021 (Research program "The use of genetic technologies for the search for biomarkers, modeling and therapy of human diseases").
Received: 2022-03-21
Accepted: 2022-03-23
Published online: 2022-07-22
|
The material is devoted to the issues of training specialists in the field of cellular biomedicine in accordance with the law «On biomedical cellular products». Cellular products based on living human somatic cells (BMCP) are a new class of therapeutic agents that reduce mortality and disability in diseases that were previously incurable. According to the program «Fundamentals of development and application of biomedical cellular products» of the Department of Cellular Biomedicine of the Russian National Research Medical University. N.I. Pirogov, students receive fundamental and applied knowledge on all stages of BMCP circulation.
Keywords: clinical trials, additional professional education, biomedical cell products, BMCP, cell biomedicine